LONDON (Reuters) -A momentous first half of 2025 comes to an end with trade, Federal Reserve independence and geopolitics staying high on the market watch list for the second half. There is plenty to ...

An international research team, including scientists from the Institut de Neurociències at the Universitat Autònoma de ...

Contrary to common fears, the reduced payments have nothing to do with Social Security’s long-term solvency. Instead, they ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

The Food and Drug Administration has granted Fast Track designation to AMX0114 for the treatment of amyotrophic lateral sclerosis (ALS).

Felzartamab is an anti-CD38 antibody that has been shown in clinical studies ... of care includes treatments ranging from immunosuppressants to chemotherapy. 2 "We are encouraged by the opportunity to ...